Antiviral agents articles within Nature

Featured

  • Article
    | Open Access

    A specific class of long phylogenetic branches, distinguished by a high proportion of G-to-A and C-to-T mutations, are almost exclusively found in sequences from 2022, after molnupiravir treatment was introduced, indicating that molnupiravir treatment can give rise to viable mutagenized viruses.

    • Theo Sanderson
    • , Ryan Hisner
    •  & Christopher Ruis

  • Article
    | Open Access

    A study reports on the antigenic characterization of SARS-CoV-2 BA.1, BA.1.1 and BA.2 and the neutralizing activity of different monoclonal antibodies and sera against them.

    • Sho Iketani
    • , Lihong Liu
    •  & David D. Ho

  • Article |

    A new treatment, containing an optimized cocktail of three monoclonal antibodies against Ebola virus, provided full protection and disease reversal in rhesus monkeys when given under conditions in which controls succumbed by day 8; this new therapy may be a good candidate for treating Ebola virus infection in human patients.

    • Xiangguo Qiu
    • , Gary Wong
    •  & Gary P. Kobinger

  • Outlook |

    There is a formidable arsenal of drugs available to treat HIV. Virginia Hughes finds that, for the first time in years, there is also renewed hope of a cure.

    • Virginia Hughes

Browse broader subjects

Browse Antiviral agents across other nature.com journals